Methanesulfonyl chloride → HCID 71721775, compound
Reaction equation
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([NH:11][C:12]2[N:26]=[C:15]3[C:16]([N:20]4[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]4)=[N:17][CH:18]=[CH:19][N:14]3[N:13]=2)[CH:6]=[C:7]([O:9][CH3:10])[CH:8]=1.[S:27]([O-])(=[O:30])(=[O:29])[CH3:28].CS(Cl)(=O)=O>>[CH3:1][O:2][C:3]1[CH:4]=[C:5]([NH:11][C:12]2[N:26]=[C:15]3[C:16]([N:20]4[CH2:25][CH2:24][N:23]([S:27]([CH3:28])(=[O:30])=[O:29])[CH2:22][CH2:21]4)=[N:17][CH:18]=[CH:19][N:14]3[N:13]=2)[CH:6]=[C:7]([O:9][CH3:10])[CH:8]=1Participants
4
Procedure
N-(3,5-dimethoxyphenyl)-8-piperazin-1-yl-[1,2,4]triazolo[1,5-a]pyrazin-2-amine (synthesized as described earlier) was converted into the mesylate by treatment with Methanesulfonylchloride under standard conditions.
Sources & evidence
- ORD record
- ord-55cc0eba526342f08d431268802dc650
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120804B2
Reaction notes
Loading…